medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2004, Número 4

<< Anterior Siguiente >>

Ann Hepatol 2004; 3 (4)


Acute liver failure and the molecular adsorbents recirculating system: Early experience in a tertiary care hospital in Mexico City

Méndez-Sánchez N, Chávez-Tapia NC, Espinoza B, Herrera-Gomar M, Zamora-Valdés D, Uribe M

Idioma: Ingles.
Referencias bibliográficas: 23
Paginas: 164-166
Archivo PDF: 41.98 Kb.


FRAGMENTO

Sin resumen


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Popper H, Schaffner F. Progress in liver diseases. Philadelphia; London: Saunders; 1990.

  2. Rakela J, Mosley JW, Edwards VM, Govindarajan S, Alpert E. A double-blinded, randomized trial of hydrocortisone in acute hepatic failure. The Acute Hepatic Failure Study Group. Dig Dis Sci. Sep 1991; 36(9): 1223-1228.

  3. Schiodt FV, Atillasoy E, Shakil AO, et al. Etiology and outcome for 295 patients with acute liver failure in the United States. Liver Transpl Surg. Jan 1999; 5(1): 29-34.

  4. Shakil AO, Kramer D, Mazariegos GV, Fung JJ, Rakela J. Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl. Mar 2000; 6(2):163-169.

  5. Ostapowicz G, Fontana RJ, Schiodt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. Dec 17 2002; 137(12): 947-954.

  6. Bernal W. Changing patterns of causation and the use of transplantation in the United kingdom. Semin Liver Dis. Aug 2003; 23(3): 227-237.

  7. Makin AJ, Wendon J, Williams R. A 7-year experience of severe acetaminophen-induced hepatotoxicity (1987-1993). Gastroenterology. Dec 1995; 109(6): 1907-1916.

  8. Bihari DJ, Gimson AE, Williams R. Cardiovascular, pulmonary and renal complications of fulminant hepatic failure. Semin Liver Dis. May 1986; 6(2): 119-128.

  9. Aggarwal S, Kramer D, Yonas H, et al. Cerebral hemodynamic and metabolic changes in fulminant hepatic failure: a retrospective study. Hepatology. Jan 1994; 19(1): 80-87.

  10. Clemmesen JO, Larsen FS, Kondrup J, Hansen BA, Ott P. Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration. Hepatology. Mar 1999; 29(3): 648-653.

  11. Lee WM. Acute liver failure in the United States. Semin Liver Dis. Aug 2003; 23(3): 217-226.

  12. Baker A, Dhawan A, Devlin J, et al. Assessment of potential donors for living related liver transplantation. Br J Surg. Feb 1999; 86(2): 200-205.

  13. Sen S, Williams R. New liver support devices in acute liver failure: a critical evaluation. Semin Liver Dis. Aug 2003; 23(3): 283-294.

  14. Chiba T, Goto S, Yokosuka O, et al. Fatal chronic active Epstein-Barr virus infection mimicking autoimmune hepatitis. Eur J Gastroenterol Hepatol. Feb 2004; 16(2): 225-228.

  15. Cacopardo B, Nunnari G, Mughini MT, Tosto S, Benanti F, Nigro L. Fatal hepatitis during Epstein-Barr virus reactivation. Eur Rev Med Pharmacol Sci. Jul-Aug 2003; 7(4): 107-109.

  16. Palanduz A, Yildirmak Y, Telhan L, et al. Fulminant hepatic failure and autoimmune hemolytic anemia associated with Epstein-Barr virus infection. J Infect. Aug 2002; 45(2): 96-98.

  17. Chen SB, Zhang LL, Shi YF, Yang XL, Wang ZH. [Application of molecular adsorbents recirculating system in the treatment for liver failure of hepatitis B]. Zhonghua Gan Zang Bing Za Zhi. Mar 2004; 12(3): 131-133.

  18. Tan HK, Lim JS, Tan CK, et al. MARS therapy in critically ill patients with advanced malignancy: a clinical and technical report. Liver Int. 2003; 23 Suppl 3: 52-60.

  19. Faybik P, Hetz H, Krenn CG, et al. Liver support in fulminant liver failure after hemorrhagic shock. Wien Klin Wochenschr. Sep 15 2003; 115(15-16): 595-598.

  20. Mitzner SR, Stange J, Klammt S, et al. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial. Liver Transpl. May 2000; 6(3): 277-286.

  21. Heemann U, Treichel U, Loock J, et al. Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study. Hepatology. Oct 2002; 36(4 Pt 1): 949-958.

  22. Sen S, Jalan R. The role of the Molecular Adsorbents Recirculating System (MARS) in the management of liver failure. Perfusion 2004; 19 Suppl 1: S43-48.

  23. Sen S, Mookerjee RP, Davies NA, Williams R, Jalan R. Review article: the molecular adsorbents recirculating system (MARS) in liver failure. Aliment Pharmacol Ther. Dec 2002; 16 Suppl 5: 32-38.




2020     |     www.medigraphic.com